X-154026729-T-C

Variant summary

Our verdict is Benign. The variant received -14 ACMG points: 0P and 14B. BP4_StrongBP6_ModerateBA1

The NM_001110792.2(MECP2):​c.*3638A>G variant causes a 3 prime UTR change involving the alteration of a non-conserved nucleotide. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★).

Frequency

Genomes: 𝑓 0.83 ( 28176 hom., 26347 hem., cov: 23)
Exomes 𝑓: 0.88 ( 77 hom. 131 hem. )
Failed GnomAD Quality Control

Consequence

MECP2
NM_001110792.2 3_prime_UTR

Scores

2

Clinical Significance

Benign criteria provided, single submitter B:1

Conservation

PhyloP100: 0.815

Publications

26 publications found
Variant links:
Genes affected
MECP2 (HGNC:6990): (methyl-CpG binding protein 2) DNA methylation is the major modification of eukaryotic genomes and plays an essential role in mammalian development. Human proteins MECP2, MBD1, MBD2, MBD3, and MBD4 comprise a family of nuclear proteins related by the presence in each of a methyl-CpG binding domain (MBD). Each of these proteins, with the exception of MBD3, is capable of binding specifically to methylated DNA. MECP2, MBD1 and MBD2 can also repress transcription from methylated gene promoters. In contrast to other MBD family members, MECP2 is X-linked and subject to X inactivation. MECP2 is dispensible in stem cells, but is essential for embryonic development. MECP2 gene mutations are the cause of most cases of Rett syndrome, a progressive neurologic developmental disorder and one of the most common causes of cognitive disability in females. Alternative splicing results in multiple transcript variants encoding different isoforms. [provided by RefSeq, Oct 2015]
MECP2 Gene-Disease associations (from GenCC):
  • chromosome Xq28 duplication syndrome
    Inheritance: XL Classification: DEFINITIVE Submitted by: G2P
  • Rett syndrome
    Inheritance: XL Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: Orphanet, Labcorp Genetics (formerly Invitae), Ambry Genetics, ClinGen, G2P
  • severe neonatal-onset encephalopathy with microcephaly
    Inheritance: XL Classification: DEFINITIVE, SUPPORTIVE Submitted by: G2P, Orphanet
  • syndromic X-linked intellectual disability Lubs type
    Inheritance: XL Classification: DEFINITIVE Submitted by: G2P
  • atypical Rett syndrome
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
  • non-syndromic X-linked intellectual disability
    Inheritance: XL Classification: SUPPORTIVE Submitted by: Orphanet
  • X-linked intellectual disability-psychosis-macroorchidism syndrome
    Inheritance: XL Classification: SUPPORTIVE Submitted by: Orphanet
  • systemic lupus erythematosus
    Inheritance: Unknown Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -14 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.58).
BP6
Variant X-154026729-T-C is Benign according to our data. Variant chrX-154026729-T-C is described in ClinVar as [Benign]. Clinvar id is 3602016.Status of the report is criteria_provided_single_submitter, 1 stars.
BA1
GnomAdExome4 highest subpopulation (AFR) allele frequency at 95% confidence interval = 0.61 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
MECP2NM_001110792.2 linkc.*3638A>G 3_prime_UTR_variant Exon 3 of 3 ENST00000453960.7 NP_001104262.1 P51608-2A0A140VKC4Q59FJ6
MECP2NM_004992.4 linkc.*3638A>G 3_prime_UTR_variant Exon 4 of 4 ENST00000303391.11 NP_004983.1 P51608-1D3YJ43Q59FJ6

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
MECP2ENST00000453960.7 linkc.*3638A>G 3_prime_UTR_variant Exon 3 of 3 1 NM_001110792.2 ENSP00000395535.2 P51608-2
MECP2ENST00000303391.11 linkc.*3638A>G 3_prime_UTR_variant Exon 4 of 4 1 NM_004992.4 ENSP00000301948.6 P51608-1
MECP2ENST00000630151.3 linkc.*3638A>G 3_prime_UTR_variant Exon 4 of 4 5 ENSP00000486089.2 A0A0D9SEX1

Frequencies

GnomAD3 genomes
AF:
0.827
AC:
91325
AN:
110435
Hom.:
28174
Cov.:
23
show subpopulations
Gnomad AFR
AF:
0.951
Gnomad AMI
AF:
0.963
Gnomad AMR
AF:
0.617
Gnomad ASJ
AF:
0.782
Gnomad EAS
AF:
0.240
Gnomad SAS
AF:
0.393
Gnomad FIN
AF:
0.857
Gnomad MID
AF:
0.711
Gnomad NFE
AF:
0.857
Gnomad OTH
AF:
0.769
GnomAD4 exome
AF:
0.875
AC:
309
AN:
353
Hom.:
77
Cov.:
0
AF XY:
0.868
AC XY:
131
AN XY:
151
show subpopulations
African (AFR)
AF:
1.00
AC:
2
AN:
2
American (AMR)
AF:
0.00
AC:
0
AN:
1
Ashkenazi Jewish (ASJ)
AF:
0.500
AC:
1
AN:
2
East Asian (EAS)
AF:
0.00
AC:
0
AN:
1
South Asian (SAS)
AC:
0
AN:
0
European-Finnish (FIN)
AF:
0.890
AC:
267
AN:
300
Middle Eastern (MID)
AC:
0
AN:
0
European-Non Finnish (NFE)
AF:
0.829
AC:
34
AN:
41
Other (OTH)
AF:
0.833
AC:
5
AN:
6
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.508
Heterozygous variant carriers
0
3
6
9
12
15
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Hom
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
Data not reliable, filtered out with message: InbreedingCoeff
AF:
0.827
AC:
91383
AN:
110489
Hom.:
28176
Cov.:
23
AF XY:
0.806
AC XY:
26347
AN XY:
32673
show subpopulations
African (AFR)
AF:
0.951
AC:
28844
AN:
30327
American (AMR)
AF:
0.616
AC:
6434
AN:
10437
Ashkenazi Jewish (ASJ)
AF:
0.782
AC:
2057
AN:
2631
East Asian (EAS)
AF:
0.240
AC:
835
AN:
3478
South Asian (SAS)
AF:
0.395
AC:
1038
AN:
2626
European-Finnish (FIN)
AF:
0.857
AC:
4979
AN:
5810
Middle Eastern (MID)
AF:
0.702
AC:
153
AN:
218
European-Non Finnish (NFE)
AF:
0.857
AC:
45239
AN:
52787
Other (OTH)
AF:
0.769
AC:
1152
AN:
1498
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.503
Heterozygous variant carriers
0
468
936
1404
1872
2340
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
720
1440
2160
2880
3600
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.828
Hom.:
83561
Bravo
AF:
0.814

ClinVar

Significance: Benign
Submissions summary: Benign:1
Revision: criteria provided, single submitter
LINK: link

Submissions by phenotype

Rett syndrome Benign:1
Dec 02, 2024
Centre for Population Genomics, CPG
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:curation

Based on the classification scheme defined by the ClinGen Rett/Angelman-like Expert Panel for Rett/AS-like Disorders Specifications to the ACMG/AMP Variant Interpretation Guidelines VCEP 3.0, this variant is classified as benign. At least the following criteria are met: The allele frequency of this variant in at least one population in gnomAD is higher than the 0.03% threshold defined by the ClinGen Rett/Angelman-like Expert Panel for Rett/AS-like Disorders VCEP 3.0 (BA1). The variant is observed in at least 2 individuals with no features of Rett Syndrome (BS2) (gnomAD homozygous count: 28253). -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.58
CADD
Benign
12
DANN
Benign
0.81
PhyloP100
0.81
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs2734647; hg19: chrX-153292180; COSMIC: COSV57653495; COSMIC: COSV57653495; API